Medicine

Zimmer Biomet Announces Fourth Quarter and Full-Year 2016 Preliminary Sales Results

Fujifilm signed the agreement to partner with R-Pharm, a major Russian pharmaceutical company, in pharmaceuticals, medical equipment and regenerative medicine

Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited

Eli Lilly and Company (NYSE: LLY) today announced that people who use Lilly insulin will be able to access discounted prices for their purchases starting January 1, 2017 via mobile and web platforms hosted by Blink Health.

Henry Schein, Inc. (Nasdaq: HSIC) announced today that it has received a perfect score of 100 percent on the 2017 Corporate Equality Index

At its December meeting, the Board of Directors (BoD) of Roche Holding decided on first proposals for approval by the Annual General Meeting (AGM), scheduled for 14 March 2017.

GE Healthcare has taken a 20% stake in global venture management company Pilot Lite Ventures (PLV), expanding its consulting business as it seeks to tap into an estimated $28 billion global market in unexploited healthcare and wellness R&D, orphaned IP and early-stage technology.

the IONA® test to be offered in the Center for Medical Genomics, Ramathibodi Hospital partnering with the Thailand Center of Excellence for Life Sciences (TCELS) 

New funding for vaccine development projects to help fight deadly diseases like Zika and Ebola.

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, reported financial results and provided corporate and clinical developments for the first quarter of fiscal year 2017, ended September 30, 2016.

Verseon will present new preclinical data on its novel class of oral anticoagulants at the American Heart Association's Scientific Sessions in New Orleans on November 15.

Bristol-Myers Squibb Company (NYSE: BMY) and Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo in combination with Infinity’s IPI-549 in patients with advanced solid tumors.

Avacta Group plc (AIM: AVCT), the developer of Affimer^® biotherapeutics and research reagents, today announced it has appointed Professor Gerard Evan, FRS, to its therapeutics Scientific Advisory Board.

Takeda Pharmaceutical Company Limited today announced that Takeda will exclusively support “Global Measles Vaccination for Children” by the United Nations Foundation’s Shot@Life campaign. The initiative aims to provide measles vacc

Cancer patients in Finland will gain access to the latest radiotherapy and radiosurgery treatments with the news that Helsinki University Hospital has ordered four advanced medical linear accelerators from Varian Medical Systems (NYSE:VAR).